Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Mast cell stabilizers control ocular itching to cat allergen
Fort Lauderdale, FL-Two pilot studies have shown that single doses of olopatadine HCl ophthalmic solution 0.1% (Patanol, Alcon Laboratories) and pemirolast potassium ophthalmic solution 0.1% (Alamast, Santen Inc./Johnson and Johnson) were comparable in reducing and controlling ocular itching in cat-sensitive individuals, according to Jason S. Rothman, MD, Cornea fellow, New England Eye Center, Tufts University School of Medicine, Boston.
Related Videos
Related Content
